Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
Harneek Chohan, Konstantin Senkevich, Radhika K. Patel, et al.
Movement Disorders (2021) Vol. 36, Iss. 6, pp. 1420-1429
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

The Impact of Type 2 Diabetes in Parkinson's Disease
Dilan Athauda, James R. Evans, Anna I. Wernick, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1612-1623
Open Access | Times Cited: 72
The heterogeneity of Parkinson’s disease
Ullrich Wüllner, Per Borghammer, Chi‐un Choe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 827-838
Open Access | Times Cited: 67
Epidemiology of Parkinson’s Disease: An Update
Juan R. Deliz, Caroline M. Tanner, Paulina Gonzàlez‐Latapi
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 6, pp. 163-179
Closed Access | Times Cited: 18
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach
Connie Marras, Seyed‐Mohammad Fereshtehnejad, Daniela Berg, et al.
Movement Disorders (2024) Vol. 39, Iss. 3, pp. 462-471
Open Access | Times Cited: 17
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 3
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, et al.
Neurologic Clinics (2025)
Closed Access | Times Cited: 2
Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders
Christian Hölscher
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 695-714
Open Access | Times Cited: 98
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
Gesine Paul, Osama F. Elabi
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 50
Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders
Nuojin Li, Tian Zhou, Erkang Fei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8281-8281
Open Access | Times Cited: 42
Glucose metabolism impairment in Parkinson’s disease
Chengcheng Dai, Changhong Tan, Lili Zhao, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110672-110672
Open Access | Times Cited: 40
Diabetes mellitus, prediabetes and the risk of Parkinson’s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases
Dagfinn Aune, Sabrina Schlesinger, Yahya Mahamat‐Saleh, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 6, pp. 591-604
Open Access | Times Cited: 33
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
The Body, the Brain, the Environment, and Parkinson’s Disease
E. Ray Dorsey, Briana R. De Miranda, Jacob Horsager, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 363-381
Open Access | Times Cited: 12
Protein–protein interactions regulating α-synuclein pathology
Jiannan Wang, Lijun Dai, Sichun Chen, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 209-226
Closed Access | Times Cited: 11
Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s Disease
Jorge Sobral, Nuno Empadinhas, A. Raquel Esteves, et al.
Nutrition Reviews (2025)
Closed Access | Times Cited: 1
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Qiu Jiang, Jie Liu, Shan Huang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK‐PD Study)
Merve Uyar, Susanne Lezius, Carsten Buhmann, et al.
Movement Disorders (2022) Vol. 37, Iss. 6, pp. 1299-1304
Open Access | Times Cited: 35
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 162-177
Closed Access | Times Cited: 33
Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment
Haiyang Yu, Tong Sun, He Xin, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1591-1591
Open Access | Times Cited: 32
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
Xiaoyan Yang, Peng Feng, Rong Ji, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 445-460
Closed Access | Times Cited: 29
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 22
Diabetes: a tipping point in neurodegenerative diseases
José A. Santiago, M. Ganesh Karthikeyan, Madison Lackey, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1029-1044
Open Access | Times Cited: 21
Parkinson's disease and cardiovascular involvement: Edifying insights (Review)
Laura Grosu, Alin Grosu, Dana Crișan, et al.
Biomedical Reports (2023) Vol. 18, Iss. 3
Open Access | Times Cited: 19
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
Osama F. Elabi, João Paulo Monteiro Carvalho Móri da Cunha, Abderahim Gaceb, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 39
Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson’s disease and co-localises with Lewy bodies
Roger Pamphlett, David Bishop
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262464-e0262464
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top